A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.
AerWave Medical has concluded the feasibility study of its ultrasound lung denervation therapy, designed to treat chronic obstructive pulmonary disease (COPD) and asthma. The first-in-human study ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions ...
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical , a leader in ultrasound-based interventional pulmonary solutions, today announced the successful completion of its first-in-human (FIH ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...
GlobalData on MSN15d
AerWave Medical concludes study of ultrasound therapy for COPDThe study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung denervation therapy. New York-based AerWave also raised $12 million to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback